InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 12/11/2017 9:20:56 AM

Monday, December 11, 2017 9:20:56 AM

Post# of 27623
ANTH - 1.60 Pre-market no at 1.83/1.84

Anthera Reports Positive Results From Phase 3 Study of Sollpura to Treat Exocrine Pancreatic Insufficiency



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.